Evidence map›Paper›PMID 25421168›Full record

ReviewNature reviews. Cardiology2015

Early detection of pulmonary arterial hypertension.

Edmund M T Lau, Marc Humbert, David S Celermajer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Pulmonary Hypertension Detection From Heart Sound Analysis.IEEE transactions on bio-medical engineering · 2025
    Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Pulmonary hypertension post-liver transplant: A case report.World journal of gastrointestinal surgery · 2024
    Article
  12. Review
  13. The latest definition and classification of pulmonary hypertension.International journal of cardiology. Congenital heart disease · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Edmund M T LauUniversity of Sydney, Sydney Medical School, Missenden Road, Camperdown, NSW 2050, Australia.
Marc HumbertUniversité Paris-Sud, Hôpital Bicêtre, AP-HP, Inserm UMR-S999, 78 Rue du Général Leclerc, Le Kremlin-Bicêtre 94270, France.
David S CelermajerUniversity of Sydney, Sydney Medical School, Missenden Road, Camperdown, NSW 2050, Australia.
The University of Sydney · AUUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary arterial hypertension (PAH) remains an incurable disease associated with an unacceptably high early mortality, despite advances in therapeutic options. The disease is clinically silent until late in its natural history, when most of the distal pulmonary arteries have been obliterated. Early diagnosis of PAH is associated with improved long-term survival, and screening of at-risk populations is, therefore, a rational strategy to improve outcomes in this condition. Doppler echocardiography is the most widely used screening tool in current clinical practice. The role of evidence-based screening strategies has been clarified by research such as the DETECT study in patients with systemic sclerosis. A multimodal approach, using a range of noninvasive tests, improves the performance of screening algorithms. Right heart catheterization is mandatory to confirm a diagnosis of PAH. Uncertainties exist about the definition and prognostic relevance of pulmonary hypertension during exercise, but accumulating evidence suggests that stress testing of the pulmonary circulation can unmask clinically important early disease. Novel tools for the early detection of pulmonary vascular disease are urgently needed, given the substantial limitations of currently available techniques.

Indexed as

AlgorithmsEarly DiagnosisEchocardiography, DopplerExercise TestHumansHypertension, PulmonaryMass ScreeningPatient Selection

Identifiers

PMID25421168
OpenAlexW2020703299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.